Hospital News and Research

RSS

Prostate patients make moves toward normality

A prompt return to usual daily activity is more likely for patients who have undergone radical prostatectomy if they start performing certain exercises soon after their operation, say researchers.

9 Jul 2012

PCV13 offers best overall protection from CAP in young children

Researchers have identified a pneumococcal conjugate vaccine that is effective for treating bacteremic pneumococcal community-acquired pneumonia in children aged 5 years or younger.

9 Jul 2012

FUJIFILM receives ONC-ATCB certification for Synapse MU 3.0 EHR technology

FUJIFILM Medical Systems U.S.A. announced today that Synapse MU 3.0, is 2011/2012 compliant and was certified as a Complete EHR on June 28, 2012 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

9 Jul 2012

Humana acquires national chronic-care provider, SeniorBridge

Humana Inc. announced today it has completed its acquisition of SeniorBridge, a national chronic-care provider best known for providing in-home care management and caregiving services for seniors.

9 Jul 2012

UMHC acquires MicroThermX Microwave Ablation System

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold a MicroThermX Microwave Ablation System to the University of Miami Hospital and Clinics to include the Sylvester Comprehensive Cancer Center and the University of Miami Hospital.

9 Jul 2012

Special surface coating for stents to keep them in place

If a person's windpipe is constricted, an operation in which the surgeon inserts a stent to enlarge the trachea is often the only way to relieve their respiratory distress. But this grid-like implant can slip out of position, closing off the windpipe altogether. Researchers are working on a special surface coating for the stents to keep them in place.

9 Jul 2012

IL announces worldwide launch of ACL TOP 300 CTS Hemostasis Testing System

Instrumentation Laboratory (IL), today, announced the worldwide commercial launch of the ACL TOP 300 CTS Hemostasis Testing System, as the newest member of the ACL TOP Family. Ideally suited for processing 50-100 patient samples per day, the ACL TOP 300 CTS offers full Testing Process Automation for low-to-medium-volume, routine or specialty Hemostasis laboratories or as an adjunct to other installed ACL TOP systems.

9 Jul 2012

Stroke Telemedicine: An interview with Séamus Watson

Stroke is the third largest cause of death in England. (1) It is a condition that requires rapid assessment and treatment to reduce deaths, disability and the risk of having another stroke. (2)

9 Jul 2012

For states, High Court's Medicaid ruling creates choices, makes waves

States are responding to the court's decision in varying ways. Some interpretations are leading states to pare back their existing Medicaid programs, according to the Wall Street Journal. Others find themselves in limbo.

9 Jul 2012

Consumer Reports investigates hospital safety

The magazine offers its rankings of the safest and most dangerous hospitals based on six criteria.

9 Jul 2012

Nurses complain about underemployment

Ever found yourself stuck in a hospital bed, pushing that little "help" button and then waiting... waiting... waiting for a nurse? That's when all the headlines about a "nursing shortage" in this country hit home, right?

9 Jul 2012

Cardinal Health to introduce new services for hospitals to leverage outpatient pharmacies

Cardinal Health will this week introduce new services that help hospitals leverage outpatient pharmacies to address two of the their most significant challenges: how to expand the quality care they provide to patients and how to increase revenue.

9 Jul 2012

Positive interim results from Inspiration's OBI-1 Phase 2/3 study for acquired hemophilia A

Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.

9 Jul 2012

HPV vaccine shows evidence of herd protection

The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens who were not immunized.

9 Jul 2012

New hemoglobin monitoring system for anemia screening introduced by OrSense Ltd.

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, GlasswingTM, its next-generation, wireless, non-invasive hemoglobin (Hb) measurement system for anemia monitoring, hemorrhage detection and pre-donation screening.

9 Jul 2012

Human immune response: TCD scientists make breakthrough which could lead to new drug therapies

A team of researchers at Trinity College Dublin’s School of Medicine has gained new insights into a protein in the human immune system that plays a key role in the protective response to infection and inflammation. The research findings have just been published in the internationally renowned peer-reviewed Journal of Biological Chemistry.

9 Jul 2012

OrSense launches Glasswing for anemia monitoring and hemorrhage detection

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, Glasswing, its next-generation, wireless, non-invasive hemoglobin (Hb) measurement system for anemia monitoring, hemorrhage detection and pre-donation screening.

9 Jul 2012

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

9 Jul 2012

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

9 Jul 2012

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

9 Jul 2012